 | • レポートコード：QYR2104Z3701 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、髄膜炎菌性疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、ワクチン）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・髄膜炎菌性疾患治療の市場動向 ・企業の競争状況、市場シェア ・髄膜炎菌性疾患治療の種類別市場規模（抗生物質、ワクチン） ・髄膜炎菌性疾患治療の用途別市場規模（病院、ドラッグストア、その他） ・髄膜炎菌性疾患治療の北米市場規模2016-2027（アメリカ、カナダ） ・髄膜炎菌性疾患治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・髄膜炎菌性疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・髄膜炎菌性疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・髄膜炎菌性疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、GlaxoSmithKline、Sanofi Pasteur、Novartis） ・結論 |
Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant risk of death associated with infection. Infection of Neisseria meningitidis may also result in mental retardation, deafness and epilepsy. 12 strains of N. meningitidis have been identified, 6 of which (A, B, C, W, X and Y) are capable enough to cause epidemics. Meningococcal septicaemia is a rare but fatal form of meningococcal disease characterized by a haemorrhagic rash and rapid circulatory collapse.
Market Analysis and Insights: Global Meningococcal Disease Treatment Market
The global Meningococcal Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Meningococcal Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Meningococcal Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Meningococcal Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Meningococcal Disease Treatment market.
Global Meningococcal Disease Treatment Scope and Market Size
Meningococcal Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibiotics
Vaccines
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
GlaxoSmithKline
Sanofi Pasteur
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global Meningococcal Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Disease Treatment Market Perspective (2016-2027)
2.2 Meningococcal Disease Treatment Growth Trends by Regions
2.2.1 Meningococcal Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Meningococcal Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Meningococcal Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Meningococcal Disease Treatment Industry Dynamic
2.3.1 Meningococcal Disease Treatment Market Trends
2.3.2 Meningococcal Disease Treatment Market Drivers
2.3.3 Meningococcal Disease Treatment Market Challenges
2.3.4 Meningococcal Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Disease Treatment Players by Revenue
3.1.1 Global Top Meningococcal Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Meningococcal Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Meningococcal Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Meningococcal Disease Treatment Revenue
3.4 Global Meningococcal Disease Treatment Market Concentration Ratio
3.4.1 Global Meningococcal Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Disease Treatment Revenue in 2020
3.5 Meningococcal Disease Treatment Key Players Head office and Area Served
3.6 Key Players Meningococcal Disease Treatment Product Solution and Service
3.7 Date of Enter into Meningococcal Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Meningococcal Disease Treatment Breakdown Data by Type
4.1 Global Meningococcal Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Meningococcal Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Meningococcal Disease Treatment Breakdown Data by Application
5.1 Global Meningococcal Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Meningococcal Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Meningococcal Disease Treatment Market Size (2016-2027)
6.2 North America Meningococcal Disease Treatment Market Size by Type
6.2.1 North America Meningococcal Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Meningococcal Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Meningococcal Disease Treatment Market Size by Type (2016-2027)
6.3 North America Meningococcal Disease Treatment Market Size by Application
6.3.1 North America Meningococcal Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Meningococcal Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Meningococcal Disease Treatment Market Size by Application (2016-2027)
6.4 North America Meningococcal Disease Treatment Market Size by Country
6.4.1 North America Meningococcal Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Meningococcal Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Meningococcal Disease Treatment Market Size (2016-2027)
7.2 Europe Meningococcal Disease Treatment Market Size by Type
7.2.1 Europe Meningococcal Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Meningococcal Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Meningococcal Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Meningococcal Disease Treatment Market Size by Application
7.3.1 Europe Meningococcal Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Meningococcal Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Meningococcal Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Meningococcal Disease Treatment Market Size by Country
7.4.1 Europe Meningococcal Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Meningococcal Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Meningococcal Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Meningococcal Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Meningococcal Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Meningococcal Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Meningococcal Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Meningococcal Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Meningococcal Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Meningococcal Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Meningococcal Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Meningococcal Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Meningococcal Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Meningococcal Disease Treatment Market Size (2016-2027)
9.2 Latin America Meningococcal Disease Treatment Market Size by Type
9.2.1 Latin America Meningococcal Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Meningococcal Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Meningococcal Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Meningococcal Disease Treatment Market Size by Application
9.3.1 Latin America Meningococcal Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Meningococcal Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Meningococcal Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Meningococcal Disease Treatment Market Size by Country
9.4.1 Latin America Meningococcal Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Meningococcal Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Meningococcal Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Meningococcal Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Meningococcal Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Meningococcal Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Meningococcal Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Meningococcal Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Meningococcal Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Meningococcal Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Meningococcal Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Meningococcal Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Meningococcal Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Meningococcal Disease Treatment Introduction
11.1.4 Pfizer Revenue in Meningococcal Disease Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Meningococcal Disease Treatment Introduction
11.2.4 GlaxoSmithKline Revenue in Meningococcal Disease Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Company Details
11.3.2 Sanofi Pasteur Business Overview
11.3.3 Sanofi Pasteur Meningococcal Disease Treatment Introduction
11.3.4 Sanofi Pasteur Revenue in Meningococcal Disease Treatment Business (2016-2021)
11.3.5 Sanofi Pasteur Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Meningococcal Disease Treatment Introduction
11.4.4 Novartis Revenue in Meningococcal Disease Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Meningococcal Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Vaccines
Table 4. Global Meningococcal Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Meningococcal Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Meningococcal Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Meningococcal Disease Treatment Market Share by Regions (2016-2021)
Table 8. Global Meningococcal Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Meningococcal Disease Treatment Market Share by Regions (2022-2027)
Table 10. Meningococcal Disease Treatment Market Trends
Table 11. Meningococcal Disease Treatment Market Drivers
Table 12. Meningococcal Disease Treatment Market Challenges
Table 13. Meningococcal Disease Treatment Market Restraints
Table 14. Global Meningococcal Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Meningococcal Disease Treatment Market Share by Players (2016-2021)
Table 16. Global Top Meningococcal Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Disease Treatment as of 2020)
Table 17. Ranking of Global Top Meningococcal Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Meningococcal Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Meningococcal Disease Treatment Product Solution and Service
Table 21. Date of Enter into Meningococcal Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Meningococcal Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Meningococcal Disease Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Meningococcal Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Meningococcal Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Meningococcal Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Meningococcal Disease Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Meningococcal Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Meningococcal Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Meningococcal Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Meningococcal Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Meningococcal Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Meningococcal Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Meningococcal Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Meningococcal Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Meningococcal Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Meningococcal Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Meningococcal Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Meningococcal Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Meningococcal Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Meningococcal Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Meningococcal Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Meningococcal Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Meningococcal Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Meningococcal Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Meningococcal Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Meningococcal Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Meningococcal Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Meningococcal Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Meningococcal Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Meningococcal Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Meningococcal Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Meningococcal Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Meningococcal Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Meningococcal Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Meningococcal Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Meningococcal Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Meningococcal Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Meningococcal Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Meningococcal Disease Treatment Product
Table 64. Pfizer Revenue in Meningococcal Disease Treatment Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Meningococcal Disease Treatment Product
Table 69. GlaxoSmithKline Revenue in Meningococcal Disease Treatment Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Sanofi Pasteur Company Details
Table 72. Sanofi Pasteur Business Overview
Table 73. Sanofi Pasteur Meningococcal Disease Treatment Product
Table 74. Sanofi Pasteur Revenue in Meningococcal Disease Treatment Business (2016-2021) & (US$ Million)
Table 75. Sanofi Pasteur Recent Development
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Meningococcal Disease Treatment Product
Table 79. Novartis Revenue in Meningococcal Disease Treatment Business (2016-2021) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Vaccines Features
Figure 4. Global Meningococcal Disease Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Drugstores Case Studies
Figure 7. Others Case Studies
Figure 8. Meningococcal Disease Treatment Report Years Considered
Figure 9. Global Meningococcal Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Meningococcal Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Meningococcal Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Meningococcal Disease Treatment Market Share by Regions (2022-2027)
Figure 13. Global Meningococcal Disease Treatment Market Share by Players in 2020
Figure 14. Global Top Meningococcal Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Disease Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Meningococcal Disease Treatment Revenue in 2020
Figure 16. Global Meningococcal Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Meningococcal Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Meningococcal Disease Treatment Market Share by Type (2016-2027)
Figure 20. North America Meningococcal Disease Treatment Market Share by Application (2016-2027)
Figure 21. North America Meningococcal Disease Treatment Market Share by Country (2016-2027)
Figure 22. United States Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Meningococcal Disease Treatment Market Share by Type (2016-2027)
Figure 26. Europe Meningococcal Disease Treatment Market Share by Application (2016-2027)
Figure 27. Europe Meningococcal Disease Treatment Market Share by Country (2016-2027)
Figure 28. Germany Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Meningococcal Disease Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Meningococcal Disease Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Meningococcal Disease Treatment Market Share by Region (2016-2027)
Figure 38. China Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Meningococcal Disease Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Meningococcal Disease Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Meningococcal Disease Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Meningococcal Disease Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Meningococcal Disease Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Meningococcal Disease Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Meningococcal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Meningococcal Disease Treatment Business (2016-2021)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Meningococcal Disease Treatment Business (2016-2021)
Figure 59. Sanofi Pasteur Revenue Growth Rate in Meningococcal Disease Treatment Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Meningococcal Disease Treatment Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
世界の髄膜炎菌性疾患治療市場 2021：企業別、地域別、種類・用途別 The Meningococcal Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- 世界の髄膜炎菌性疾患治療薬市場 2021：企業別、地域別、種類・用途別 The Meningococcal Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界のクラッベ病治療市場規模・現状・予測（2021年-2027年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- 世界の菌結合型髄膜炎市場規模・現状・予測（2021年-2027年） Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meni…
- 世界のニューカッスル病治療市場規模・現状・予測（2021年-2027年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…